Official Title
Comparison of Two Strategies for Glycemic Control in Acute Ischemic Stroke
Phase
Phase 4Lead Sponsor
Hospital Sao DomingosStudy Type
InterventionalStatus
Unknown statusIndication/Condition
Acute Ischemic StrokeIntervention/Treatment
insulin human ...Study Participants
70The purpose of this prospective randomized controlled trial was to compare intensive insulin therapy with a carbohydrate restrictive strategy in patients with acute ischemic stroke evaluating the outcome through the Glasgow Outcome Scale Extended, hospital mortality and NIHSS during the ICU stay.
Patients will receive intravenous hydration with a glucose free solution (Ringer III) and enteral nutritional formula containing 33.3% carbohydrates, 16.7% proteins and 50% lipids. These patients will receive regular insulin subcutaneously four times daily, aiming to maintain blood glucose levels at least below 180 mg/dl, and in stable patients, ideally below 150 mg/dl.
Continuous intravenous regular insulin infusion will be adjusted to maintain glycemic levels at least below 150 mg/dl, and, in stable patients and ideally, between 80 and 120 mg/dl. Patients will be submitted to capillary glycemic measurements every 2 hours. The insulin dose is adjusted according to an algorithm run by nurses and overseen by physicians. These patients will receive glucosaline (5% glucose + 0.9 NaCl) hydration and enteral nutrition with a formula containing 45% carbohydrates, 17% proteins and 38% lipids.
Inclusion Criteria: Adult patients with acute ischemic stroke defined as: Abrupt onset of focal neurologic deficit No evidence of intracranial hemorrhage at non-contrasted CT scan. Exclusion Criteria: Age below 18 Pregnancy
